Dec 02,2015

Nemaura Medical Announces Joint Venture for European Launch of sugarBEAT® System

Nemaura Medical Inc., a medical device company developing a minimally invasive wireless continuous glucose monitoring system known as sugarBEAT, announced today that it has entered into an equal Joint Venture agreement with DBJ Jersey to market the sugarBEAT system in Europe. The company anticipates a launch in Europe during 2016, pending obtaining requisite product approvals, for which the operational aspects of the launch will be entirely managed by DBJ Jersey under the terms of the agreement, with product support from Nemaura Medical.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 11,2014

Joslin Diabetes Center adds digital health division, partners with Dexcom

Boston-based Joslin Diabetes Center has created a new non-profit division, called Joslin Institute for Technology Translation (JITT), so that the healthcare organization can collaborate with companies currently developing tools for people with diabetes, according to a press release. The new division will work with physicians to design decision support tools for managing insulin and glucose tracking, partner with medical device and technology companies so that Joslin can push for the creation of digital health tools focused on diabetes, and develop educational programs that help healthcare professionals and patients adopt the new tools. Joslin's first partnership is with San Diego, California-based Dexcom, maker of continuous glucose monitoring systems for patients.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 25,2022

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around insulin management.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jun 07,2022

Included Health Expands Platform Connectivity with the Healthcare Ecosystem to Deliver Better Member Care

Included Health, the only integrated virtual care and navigation platform, today announced it has launched a new partner ecosystem platform feature that enables deep data and app integration capabilities with select healthcare partners, including Virta Health.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Aug 17,2022

Vision Loss Rehabilitation Canada Brings Ai-Driven Diabetic Eye Screening to Rural and Indigenous Communities

Vision Loss Rehabilitation Canada Canada’s leading provider of rehabilitation therapy and healthcare services for individuals with vision loss, and Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, announced the launch of VLRC’s Eye Health Screening Initiative to screen rural, remote and Indigenous populations in Northern and Eastern Ontario for diabetic retinopathy (DR), the leading cause of blindness among working age adults, using Eyenuk’s autonomous AI technology.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Feb 18,2021

Brighter signs 5-year distribution agreement for Actiste in Qatar

Brighter AB has signed a five-year distribution agreement with Al Danah Medical Company in Qatar regarding Brighter’s pioneering product portfolio for diabetes management Actiste®. Both Actiste® and the newly developed Actiste® Mini are included in the agreement. With Qatar’s healthcare system being primarily state-run the outcome of the agreement will largely depend on the Distributor’s ability to win public tenders. Based on the distributor's experience and position in Qatar, Brighter is optimistic about the distributor's ability to win such contracts. Brighter will work closely with Al Danah to achieve this. The Distributor also has ambitions to market the Actiste® product portfolio through its chain of pharmacies. 

COLLABORATION PARTNERSHIP

#institution

#bgm

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Mar 02,2021

CentraState Healthcare System Partners With Noteworth to Deliver Telemedicine Services and Extend Care Management Capabilities

Noteworth, a first-of-its-kind virtual care delivery platform including diabates services, announced its partnership with CentraState Healthcare System to extend the continuity of care for patients in the community. CentraState recently implemented Noteworth to launch multiple programs to expand their care delivery, including telehealth and remote prevention and care management capabilities for diabetes and hypertension.

COLLABORATION PARTNERSHIP

#institution

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 07,2021

Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes

Medtronic today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jul 27,2021

Brighter enters into commercial collaboration agreement with VivBon AB in Sweden for the Actiste® portfolio

Brighter AB announced today that the company has entered into a commercial collaboration agreement with VivBon AB,a Swedish service provider that offers a wide range of personalized services and solutions for seniors and their relatives, to sell Brighter’s Actiste® and Actiste® Mini portfolio for diabetes management. Under this collaboration agreement, Vivbon will actively offer and sell Actiste® and Actiste® Mini to its customers.

COLLABORATION PARTNERSHIP

#institution

#insulin pen

#bgm

View Analyst & Ambassador Comments
Go to original news
Sep 14,2021

Leon Medical Centers Partners with Health Tech Company Rimidi, Reducing A1Cs in High-Risk Cohort of Patients with Type 2 Diabetes

Leon Medical Centers today announced clinical improvements in a cohort of high-risk patients with Type 2 Diabetes due to the remote patient monitoring and clinical decision support capabilities of Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives. Leon began using the Rimidi platform, which integrates directly with their Epic electronic health record (EHR), at the beginning of 2020. 

COLLABORATION PARTNERSHIP

#institution

#rpm

#bgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION